However, the relationship between BMI and response to biologic therapies is not uniformly consistent across studies
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest Statements Conflict of interest Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma
Mannitol is a filler that is added to peptides as a bulking agent
Rampersad SN (2012) Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays
Amelanotic melanoma Amelanotic melanoma Amelanotic melanoma What are the dermoscopic features of amelanotic melanoma